Keysight: Spirent step-up masks a normalizing margin base that the market hasn't repriced

Stevie AI on Keysight Technologies Inc (KEYS-USA | keysighttech)

9/1/2026

Summary

Keysight is the #1-2 global player in electronic test and measurement, selling instruments, software and subscriptions that sit at every stage of the innovation lifecycle from pre-silicon design to network deployment. The company just closed a transformative combination with Spirent and expanded its RF portfolio, layering a durable revenue base onto a business already riding record demand for 5G/6G, AI infrastructure validation, and defense electronics. The key structural insight is that FY2026's eye-popping growth (+32% revenue, +60% EPS) is a mix of a genuine step-change in scale and a one-time ~$1B tariff benefit that will not repeat — yet the underlying earnings power in FY2027-2029, even after normalization, sits meaningfully above where Keysight traded historically, and the market has not yet given the stock credit for the post-acquisition steady state. Historically the numbers were modest: FY2024 revenue of $5.0B produced net income of just $0.6B and EPS of $3.51; FY2025 improved to $5.4B revenue, $0.9B net income and $4.88 EPS as organic demand and early synergy realization built. FY2026 guidance implies a completely different scale of business — $7.9B revenue, $2.1B net income, and $12.00 EPS — reflecting the Spirent/RF acquisitions closing plus a demand pull-through that management describes as record bookings and backlog, even as supply chain constraints act as an explicit governor on how much of that demand converts to shipped revenue. Our price targets are built off the EPS path of $12.00 (FY26), $11.92 (FY27), $12.98 (FY28) and $14.11 (FY29), applying a 27x forward P/E — a premium to the historical test & measurement group multiple (typically 18-22x) but justified by the margin structure moving permanently higher post-synergy, net cash turning strongly positive by FY2027 ($1.3B) and FY2029 ($3.8B), and a growth profile now anchored by durable secular demand in AI infrastructure validation, 6G standardization work, and defense modernization. At 27x FY2027 normalized EPS of $11.92, we derive a price target of roughly $322 for FY2027, rising to $351 by FY2028 and $381 by FY2029, representing mid-teens % upside by FY2029 from current levels of $322.70, with FY2026's target essentially in line with the FY2026 EPS spike already reflected in consensus expectations.

Thesis

1. **Scale step-change is real, not just financial engineering.** The Spirent and RF-related acquisitions push Keysight's revenue base from ~$5.4B to a run-rate closer to $8-9B within two years. This isn't simply multiple arbitrage on debt-funded EPS accretion — the acquired assets slot directly into Keysight's core competency of protocol/network validation and RF test, expanding TAM into areas like network security testing and higher-frequency RF measurement that are becoming mandatory as 5G-Advanced and 6G standards approach. The FY2026 guide of $7.88B revenue at the midpoint, +32% YoY, reflects both the acquisition contribution and record organic bookings, evidence the combination is additive to demand rather than merely consolidative. 2. **Margin normalization is well-telegraphed and already embedded in our forecast — the market may be overreacting to the FY2027 dip.** Management has been explicit: the ~$1B tariff benefit and elevated gross margins (69% vs. a stated sustainable upper-60s%) driving FY2026's outsized 33.2% operating margin will partially reverse in FY2027, pulling operating margin back toward the 31-32% long-term target. Our FY2027 EPS of $11.92 (essentially flat versus FY2026's $12.00) already reflects this normalization. If the market extrapolates the FY2026 EPS growth rate as sustainable, current valuation multiples applied to FY2026 numbers would look cheap; if it fixates on the FY2027 EPS deceleration as a red flag, the stock could see undue pressure despite normalized earnings power still being roughly 3.4x FY2024 levels. 3. **Synergy realization provides a genuine, quantified offset to margin normalization.** Unlike vague 'synergy' promises common in M&A, management has given hard numbers: $90M run-rate synergies exiting FY2026, with another $50M incremental into FY2027. This directly cushions the tariff-benefit reversal and supports our view that FY2027 EPS holds essentially flat rather than declining, a distinguishing feature versus typical post-acquisition margin compression stories. 4. **Balance sheet inflects from acquisition-funded leverage to a net cash compounding machine within three years.** Net cash moves from roughly $0.1B in FY2026 to $1.3B (FY2027), $2.5B (FY2028) and $3.8B (FY2029), driven by FCF generation of $1.7-2.1B annually. This provides substantial optionality for continued buybacks, further bolt-on M&A in adjacent test categories (AI workload emulation, silicon photonics), or dividend initiation — any of which could serve as positive re-rating catalysts as the deleveraging story becomes visible in reported financials. 5. **Supply chain constraint is a demand-storage mechanism, not a demand-destruction one.** Management's characterization of supply chain as the 'governor' of near-term revenue — rather than citing softening bookings — implies the backlog is being built rather than lost. As NPI ramp issues and component constraints ease over 'several quarters,' this backlog should convert to revenue recognition, providing a visible glide path of upside to FY2027-2028 numbers versus a scenario where demand simply doesn't exist. 6. **Structural leadership in a market experiencing genuine TAM expansion, not just cyclical recovery.** Keysight's position spanning pre-silicon design through system-level emulation and manufacturing compliance gives it exposure to multiple secular waves simultaneously — AI infrastructure validation, 6G standardization (first standard targeted March 2029), silicon photonics, and defense/ADG modernization. Competitors like Anritsu and R&S compete on narrower instrument classes; Keysight's breadth across the full innovation lifecycle is difficult to replicate and supports premium market share retention even as new entrants target specific niches.

Risks

1. **Tariff benefit reversal could be larger or faster than modeled.** The ~$1B one-time tariff benefit in FY2026 is treated as fully non-recurring in our FY2027 estimates, but if trade policy shifts again (in either direction) the actual swing could be more volatile than the smooth normalization we've assumed, creating EPS estimate risk in either direction. 2. **Supply chain constraints could persist longer than 'several quarters,' capping the backlog conversion thesis.** If component availability issues in the broader semiconductor ecosystem extend well into FY2027-2028, the assumed reacceleration of organic growth in our out-year estimates may not materialize on schedule, delaying the earnings power investors are being asked to underwrite today. 3. **Integration risk on Spirent/RF acquisitions is non-trivial given the scale of the step-up.** Moving from a $5.4B revenue base to $7.9B within a single fiscal year via acquisition is an aggressive integration timeline. Realizing the stated $90M/$140M cumulative synergies requires successful systems, sales-force, and product roadmap integration — any slippage directly pressures the FY2027 margin bridge we've modeled. 4. **Rising interest expense on acquisition debt partially offsets net income growth.** While net cash turns positive by FY2027, the intervening period carries elevated leverage from acquisition financing. If rates stay higher for longer or refinancing terms are unfavorable, interest expense could erode more of the EPS growth than currently assumed. 5. **Premium multiple assumption (27x) is vulnerable to sector de-rating.** Hardware/equipment names in technology can see multiple compression quickly if growth decelerates or if the market rotates away from capex-linked cyclicals. Our price targets are highly sensitive to multiple assumptions — a compression to 20-22x (closer to historical T&M sector averages) would reduce price targets by roughly 20-25% even with EPS estimates unchanged. 6. **Customer concentration and cyclicality in semiconductor/wireless capex cycles.** Keysight's EISG and CSG segments are both exposed to lumpy capital equipment spending cycles from semiconductor fabs, wireless carriers, and defense budgets. A downturn in any of these end markets — particularly a pause in AI infrastructure buildout or a delay in 6G capex timelines — could reduce bookings well before backlog is fully worked through, creating a sharper-than-expected deceleration.

📈 Price Targets